![Alexandra Balcom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexandra Balcom
Director of Finance/CFO at
NUVALENT, INC.
Net worth: 9 M $ as of 2026-05-30
Profile
Ms. Alexandra Balcom is an Independent Director at Crescent Biopharma, Inc. and a Chief Financial Officer & Treasurer at Nuvalent, Inc. She is on the Board of Directors at Crescent Biopharma, Inc. Ms. Balcom was previously employed as a Vice President-Finance by SQZ Biotechnologies Co. and a Controller by Agios Pharmaceuticals, Inc. She also served on the board at Crescent Biopharma, Inc. (Old).
She received her undergraduate degree from the University of Massachusetts and an MBA from Boston College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-30 | 85,533 ( 0.12% ) | 9 M $ | 2026-05-30 | |
-.--% | 2026-06-01 | 0 ( -.--% ) | - $ | 2026-05-30 |
Alexandra Balcom active positions
| Companies | Position | Start |
|---|---|---|
| NUVALENT, INC. | Director of Finance/CFO | 2020-12-31 |
Former positions of Alexandra Balcom
| Companies | Position | End |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Corporate Officer/Principal | 2021-02-28 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Training of Alexandra Balcom
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
- Stock Market
- Insiders
- Alexandra Balcom
Choose MarketScreener 
